Ardsley Advisory Partners LP Horizon Therapeutics Public LTD CO Transaction History

Ardsley Advisory Partners LP

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$79.4 - $116.36 $1.99 Million - $2.91 Million	-25,000 Reduced 29.41%	60,000 $4.79 Million
Q1 2022 May 16, 2022	SELL	$86.42 - $109.81 $4.75 Million - $6.04 Million	-55,000 Reduced 39.29%	85,000 $8.94 Million
Q4 2021 Feb 14, 2022	SELL	$98.56 - $119.91 $13.4 Million - $16.3 Million	-136,000 Reduced 49.28%	140,000 $15.1 Million
Q3 2021 Nov 15, 2021	SELL	$91.91 - $110.37 $827,190 - $993,330	-9,000 Reduced 3.16%	276,000 $30.2 Million
Q2 2021 Aug 16, 2021	BUY	$86.24 - $95.92 $3.02 Million - $3.36 Million	35,000 Added 14.0%	285,000 $26.7 Million
Q1 2021 May 17, 2021	BUY	$71.83 - $95.48 $3.59 Million - $4.77 Million	50,000 Added 25.0%	250,000 $23 Million
Q4 2020 Feb 16, 2021	BUY	$67.0 - $84.39 $4.36 Million - $5.49 Million	65,000 Added 48.15%	200,000 $14.6 Million
Q3 2020 Nov 13, 2020	BUY	$55.23 - $79.93 $7.46 Million - $10.8 Million	135,000 New	135,000 $10.5 Million

2.07M

20K

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

Get notified when there are updates to the investment portfolio of Ardsley Advisory Partners LP, based on Form 13F filings with the SEC.

Stay updated on Ardsley Advisory Partners LP with notifications on news.